Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer

Clinical trial NCT06631521 · RECRUITING

Trial details

NCT number: NCT06631521
Sponsor: AdventHealth
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate CA Prostate Cancer (Adenocarcinoma)Prostate Cancer Surgery

Start date: 2024-10-22
Primary completion: 2026-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.